Item is in stockHurry! Low InventoryItem is out of stock. Item is unavailable
Need to speak with a clinician?

Schedule a telehealth consultation with a practitioner specialized in peptide therapy, who will review your medical history and determine the best plan for you.

Proper Handling

Product Specifications: 5mg Lyophilized Powder (>98% purity) in 4ml vial.*Requires reconstitution with solvent such as Bacteriostatic Water. Speak to a qualified healthcare professional if you are considering peptide therapy.

Improves Energy
Increase Muscle Strength
Improved Cognitive Function
Accelerates Healing and Recovery
Increases Collagen Production

Ipamorelin has been said to be the most effective growth hormone-releasing peptide (GHRP). Ipamorelin is a pentapeptide (a peptide composed of five amino acids) and GH receptor agonist that offers many potential benefits for health and wellness. It stimulates the release of growth hormone from the anterior pituitary gland, which may influence pain relief and regulate bodily growth, thyroid function, and body temperature.

Ipamorelin can also help decrease water retention for patients struggling with rapid weight gain, leading to accelerated fat loss and an increase in lean muscle mass.

CAS Number 170851-70-4

PubChem CID 9831659

Molecular Weight 711.9 g/mol

Molecular Formula C38H49N9O5

Synonyms NNC-260161, NNC 26-0161, NNC-26-0161, NCGC00167295-01, AS-56185

Storage (Lyophilized)

At 39 Fahrenheit: 2 years
At -4 Fahrenheit: 3 years

  1. A Giustina, JD Veldhius, Pathophysiology of the neuro regulation of growth hormone secretion in experimental animals and the human, Endocrinology, 1 December 1998.
  2. David E. Beck et al., Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients, International Journal of Colorectal Disease, 2014.
  3. K. Raun et al., Ipamorelin, the first selective growth hormone secretagogue, Endocrinology, November 1998.
  4. P.B Johansen et al, Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats, Growth Hormone IGF Research, April 1999.
  5. Gobburu, J.V.S., Agersø, H., Jusko, W.J. et al. Pharmacokinetic-Pharmacodynamic Modeling of Ipamorelin, a Growth Hormone Releasing Peptide, in Human Volunteers. Pharm Res 16, 1412–1416 (1999).
  6. Rogério G. Gondo et al, Growth Hormone-Releasing Peptide-2 Stimulates GH Secretion in GH-Deficient Patients with Mutated GH-Releasing Hormone Receptor, The Journal of Clinical Endocrinology & Metabolism, Volume 86, Issue 7, 1 July 2001, Pages 3279–3283.
  7. Mericq V, Cassorla F, Salazar T, Avila A, Iñiguez G, Bowers CY, Merriam GR. Effects of eight months treatment with graded doses of a growth hormone (GH)-releasing peptide in GH-deficient children. J Clin Endocrinol Metabolism, Jul 1998; 83(7):2355-60.
  8. Sinha, D. K., Balasubramanian, A., Tatem, A. J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A. W., & Lipshultz, L. I. (2020). Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational andrology and urology, 9(Suppl 2), S149–S15.

Buy It With

BPC-157 / TB-500 Blend


 TB-500 Blend

Buy It With

Bacteriostatic Water


Bacteriostatic Water

Frequently Asked Questions


Free Shipping

on all orders over $200 delivered straight to your doorstep

Easy Telehealth

Ongoing care available, 100% online at your convenience

Quality First

All peptides are clinical grade and undergoes third-party testing

Proactive Care

Your journey, your way. We are here to support your health goals.

Your body, your health, your journey .

Embarking on the journey to better health involves embracing holistic well-being through consultative care. Schedule an appointment with a medical provider to get ongoing support and a treatment plan for peptide therapy.